Pilianidis G, Papanastasiou G, Tikoudi P, Themistocleous A, Farmakis G, Dolianitis K. Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections? EJCRIM [Internet]. 2024 Feb. 2 [cited 2026 Nov. 3];11(3). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4282